• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用不同化学计量学支持模型对药物制剂及加标人血浆样品中法匹拉韦和瑞德西韦进行校正的绿色分光光度法测定。

Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models.

作者信息

Imam Mohamed S, Abdelazim Ahmed H, Ramzy Sherif, Batubara Afnan S, Gamal Mohammed, Abdelhafiz Safwan, Zeid Abdallah M

机构信息

Pharmacy Practice Department, College of Pharmacy, Shaqra University, Shaqra, 11961, Saudi Arabia.

Clinical Pharmacy Department, National Cancer Institute, Cairo University, Fom El Khalig Square, Kasr Al-Aini Street, Cairo, 11796, Egypt.

出版信息

BMC Chem. 2023 Jul 27;17(1):89. doi: 10.1186/s13065-023-01001-5.

DOI:10.1186/s13065-023-01001-5
PMID:37501208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10373238/
Abstract

The environmentally friendly design of analytical methods is gaining interest in pharmaceutical analysis to reduce hazardous environmental impacts and improve safety and health conditions for analysts. The adaptation and integration of chemometrics in the development of environmentally friendly analytical methods is strongly recommended in the hope of promising benefits. Favipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries. The main objective of this work is to develop green, tuned spectrophotometric methods based on chemometric based models for the determination of favipiravir and remdesivir in spiked human plasma. The UV absorption spectra of favipiravir and remdesivir has shown overlap to some extent, making simultaneous determination difficult. Three advanced chemometric models, classical least squares, principal component regression, and partial least squares, have been developed to provide resolution and spectrophotometric determination of the drugs under study. A five-level, two-factor experimental design has been used to create the described models. The spectrally recorded data of favipiravir and remdesivir has been reviewed. The noise region has been neglected as it has a negative impact on the significant data. On the other hand, the other spectral data provided relevant information about the investigated drugs. A comprehensive evaluation and interpretation of the results of the described models and a statistical comparison with accepted values have been considered. The proposed models have been successfully applied to the spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form spiked human plasma. In addition, the environmental friendliness of the described models was evaluated using the analytical eco-scale, the green analytical procedure index and the AGREE evaluation method. The results showed the compliance of the described models with the environmental characteristics.

摘要

分析方法的环保设计在药物分析领域正日益受到关注,旨在减少对环境的有害影响,并改善分析人员的安全与健康状况。强烈建议在环保分析方法的开发中采用并整合化学计量学,以期获得可观的效益。法匹拉韦和瑞德西韦已被纳入多个国家的新冠治疗指南专家组。本研究的主要目的是基于化学计量学模型开发绿色、优化的分光光度法,用于测定加标人血浆中法匹拉韦和瑞德西韦的含量。法匹拉韦和瑞德西韦的紫外吸收光谱在一定程度上存在重叠,使得同时测定变得困难。已开发了三种先进的化学计量学模型,即经典最小二乘法、主成分回归法和偏最小二乘法,以实现对所研究药物的分辨率和分光光度测定。采用五级二因素实验设计来构建所述模型。对法匹拉韦和瑞德西韦的光谱记录数据进行了审查。噪声区域因其对重要数据有负面影响而被忽略。另一方面,其他光谱数据提供了有关所研究药物的相关信息。已对所述模型的结果进行了全面评估和解释,并与公认值进行了统计比较。所提出的模型已成功应用于分光光度法测定加标人血浆中药物制剂中法匹拉韦和瑞德西韦的含量。此外,使用分析生态尺度、绿色分析程序指数和AGREE评估方法对所述模型的环境友好性进行了评估。结果表明所述模型符合环境特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/fdd8389e0070/13065_2023_1001_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/234c3b2bbcd2/13065_2023_1001_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/01e3454c7fb7/13065_2023_1001_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/3e97d3834aed/13065_2023_1001_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/e14d51218f88/13065_2023_1001_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/aa458b158dc7/13065_2023_1001_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/fdd8389e0070/13065_2023_1001_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/234c3b2bbcd2/13065_2023_1001_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/01e3454c7fb7/13065_2023_1001_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/3e97d3834aed/13065_2023_1001_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/e14d51218f88/13065_2023_1001_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/aa458b158dc7/13065_2023_1001_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033b/10373238/fdd8389e0070/13065_2023_1001_Fig6_HTML.jpg

相似文献

1
Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models.使用不同化学计量学支持模型对药物制剂及加标人血浆样品中法匹拉韦和瑞德西韦进行校正的绿色分光光度法测定。
BMC Chem. 2023 Jul 27;17(1):89. doi: 10.1186/s13065-023-01001-5.
2
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation.使用分光光度法对加标的人血浆中两种新冠病毒抗病毒药物法匹拉韦和瑞德西韦进行定量分析;绿色度评估。
BMC Chem. 2023 Jun 16;17(1):58. doi: 10.1186/s13065-023-00967-6.
3
Green chemometric-assisted UV-spectrophotometric methods for the determination of favipiravir, cefixime and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in pharmaceutical form and spiked human plasma.绿色化学计量学辅助紫外分光光度法测定法匹拉韦、头孢克肟和盐酸莫西沙星作为COVID-19的有效治疗组合;在药物剂型和加标人血浆中的应用
BMC Chem. 2024 Apr 5;18(1):65. doi: 10.1186/s13065-024-01168-5.
4
Chemometric Assisted UV-Spectrophotometric Methods Using Multivariate Curve Resolution Alternating Least Squares and Partial Least Squares Regression for Determination of Beta-Antagonists in Formulated Products: Evaluation of the Ecological Impact.化学计量学辅助的紫外分光光度法,采用多元曲线分辨交替最小二乘法和偏最小二乘回归,用于测定配方产品中的β-受体拮抗剂:生态影响评估。
Molecules. 2022 Dec 31;28(1):328. doi: 10.3390/molecules28010328.
5
Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.纳米级人血浆中扎那米韦和阿司匹林的同步荧光光度法测定;绿色度评价。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Oct 15;299:122880. doi: 10.1016/j.saa.2023.122880. Epub 2023 May 16.
6
Development and Evaluation of Chemometric Models for the Estimation of Sumatriptan in the Presence of Naproxen and a Degradation Product Using UV Spectrophotometry.利用紫外分光光度法在存在萘普生和一种降解产物的情况下估算舒马曲坦的化学计量学模型的开发与评估
J AOAC Int. 2024 Oct 1;107(5):749-760. doi: 10.1093/jaoacint/qsae041.
7
A green spectrophotometric method for the simultaneous determination of nasal binary mixture used in respiratory diseases: Applying isosbestic point and chemometric approaches as a resolving tool, greenness evaluation.一种用于同时测定呼吸系统疾病中使用的鼻用二元混合物的绿色分光光度法:应用等色点和化学计量学方法作为解析工具,进行绿色度评估。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Dec 15;283:121585. doi: 10.1016/j.saa.2022.121585. Epub 2022 Jul 2.
8
Novel environment friendly TLC-densitometric method for the determination of anti-coronavirus drugs "Remdesivir and Favipiravir": Green assessment with application to pharmaceutical formulations and human plasma.用于测定抗冠状病毒药物“瑞德西韦和法匹拉韦”的新型环保薄层色谱-密度测定法:应用于药物制剂和人体血浆的绿色评估
Microchem J. 2022 Mar;174:107101. doi: 10.1016/j.microc.2021.107101. Epub 2021 Dec 18.
9
Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.人血浆中扎那米韦、瑞德西韦和羟氯喹的荧光分光光度定量分析。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Nov 15;281:121625. doi: 10.1016/j.saa.2022.121625. Epub 2022 Jul 13.
10
Spider chart, greenness and whiteness assessment of experimentally designed multivariate models for simultaneous determination of three drugs used as a combinatory antibiotic regimen in critical care units: Comparative study.蜘蛛图,设计用于同时测定三种药物的多变量模型的实验性的绿色和白色评估,这些药物在重症监护病房中作为联合抗生素方案使用:比较研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2024 May 15;313:124115. doi: 10.1016/j.saa.2024.124115. Epub 2024 Mar 4.

引用本文的文献

1
Multivariate classical least squares-based model for spectrophotometric determination of celecoxib and Tramadol in their new formulated dosage form.基于多元经典最小二乘法的分光光度法测定新剂型中塞来昔布和曲马多的模型
BMC Chem. 2025 Aug 31;19(1):254. doi: 10.1186/s13065-025-01605-z.
2
Selective six spectrophotometric methods for determination of remdesivir and moxifloxacin hydrochloride for COVID-19 treatment with overlapping spectra: a comprehensive evaluation of greenness, blueness, and whiteness.用于测定治疗新冠肺炎的瑞德西韦和盐酸莫西沙星的选择性六种分光光度法:重叠光谱下绿色度、蓝色度和白度的综合评估
BMC Chem. 2025 Aug 21;19(1):246. doi: 10.1186/s13065-025-01607-x.
3

本文引用的文献

1
Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form.基于计算的绿附分光光度法测定莫努匹韦;应用于最近获得 FDA 批准的药物剂型。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jan 15;285:121911. doi: 10.1016/j.saa.2022.121911. Epub 2022 Sep 22.
2
Different spectrophotometric methods for simultaneous determination of lesinurad and allopurinol in the new FDA approved pharmaceutical preparation; additional greenness evaluation.不同分光光度法同时测定新 FDA 批准药物制剂中雷西纳德和别嘌醇的含量;额外的绿色评估。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jan 15;285:121868. doi: 10.1016/j.saa.2022.121868. Epub 2022 Sep 10.
3
A quality-by-design optimized LC method for navigating degradation kinetics and quantification of favipiravir in the presence of degradation products and manufacturing impurities.
一种基于质量源于设计理念优化的液相色谱方法,用于在存在降解产物和生产杂质的情况下研究法匹拉韦的降解动力学并进行定量分析。
BMC Chem. 2025 Aug 15;19(1):244. doi: 10.1186/s13065-025-01610-2.
4
Utility of green chemistry for spectrofluorometric and spectrophotometric analysis of vericiguat via reaction with erythrocin B.绿色化学在通过与赤藓红B反应对维立西呱进行荧光分光光度法和分光光度法分析中的应用。
BMC Chem. 2025 May 6;19(1):118. doi: 10.1186/s13065-025-01485-3.
5
Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma.首例获批的抗病毒药物瑞德西韦与左羟丙哌嗪联用治疗新冠肺炎的绿色同步荧光光谱分析:在其药物剂型及加标人血浆中的应用
BMC Chem. 2025 May 2;19(1):115. doi: 10.1186/s13065-025-01480-8.
6
Comparative study of Normal-phase versus reversed-phase HPTLC methods for the concurrent quantification of three antiviral agents against COVID19: Remdesivir, favipiravir and Molnupiravir: trichromatic sustainability assessment.正相高效薄层色谱法与反相高效薄层色谱法对三种抗新冠病毒药物(瑞德西韦、法匹拉韦和莫努匹拉韦)同时定量的比较研究:三色可持续性评估
BMC Chem. 2025 Mar 28;19(1):83. doi: 10.1186/s13065-025-01439-9.
7
Ecofriendly spectrophotometric methods for simultaneous determination of remdesivir and moxifloxacin hydrochloride as co administered drugs in corona virus treatment.用于同时测定作为冠状病毒治疗中联合给药的瑞德西韦和盐酸莫西沙星的环保型分光光度法。
Sci Rep. 2025 Jan 11;15(1):1721. doi: 10.1038/s41598-024-83049-4.
8
Application of signal processing techniques for the spectroscopic analysis of dolutegravir and lamivudine: a comparative assessment and greenness appraisal.信号处理技术在多替拉韦和拉米夫定光谱分析中的应用:比较评估与绿色度评价
BMC Chem. 2024 Jul 8;18(1):129. doi: 10.1186/s13065-024-01226-y.
Insights on the Quantitative Concurrent Fluorescence-Based Analysis of Anti-COVID-19 Drugs Remdesivir and Favipiravir.抗新冠病毒药物瑞德西韦和法匹拉韦的定量荧光同步分析的研究进展。
J Fluoresc. 2022 Sep;32(5):1941-1948. doi: 10.1007/s10895-022-02998-z. Epub 2022 Jun 30.
4
Spectrophotometric quantitative analysis of remdesivir using acid dye reagent selected by computational calculations.使用通过计算筛选出的酸性染料试剂对瑞德西韦进行分光光度法定量分析。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Aug 5;276:121188. doi: 10.1016/j.saa.2022.121188. Epub 2022 Mar 31.
5
Novel environment friendly TLC-densitometric method for the determination of anti-coronavirus drugs "Remdesivir and Favipiravir": Green assessment with application to pharmaceutical formulations and human plasma.用于测定抗冠状病毒药物“瑞德西韦和法匹拉韦”的新型环保薄层色谱-密度测定法:应用于药物制剂和人体血浆的绿色评估
Microchem J. 2022 Mar;174:107101. doi: 10.1016/j.microc.2021.107101. Epub 2021 Dec 18.
6
Comparison of HPLC and UV Spectrophotometric Methods for Quantification of Favipiravir in Pharmaceutical Formulations.高效液相色谱法与紫外分光光度法用于药物制剂中法匹拉韦定量分析的比较
Iran J Pharm Res. 2021 Summer;20(3):57-65. doi: 10.22037/ijpr.2020.114199.14725.
7
A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling.一种用于测定法匹拉韦(一种用于治疗COVID-19的潜在抗病毒药物)的新型稳定性指示高效液相色谱-二极管阵列检测法;应用于降解动力学研究和体外溶出度分析。
Microchem J. 2022 Jan;172:106917. doi: 10.1016/j.microc.2021.106917. Epub 2021 Oct 15.
8
ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential.瑞德西韦的吸收、分布、代谢、排泄及药代动力学特性:其药物相互作用潜力
Pharmaceuticals (Basel). 2021 Jul 8;14(7):655. doi: 10.3390/ph14070655.
9
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials.法维拉韦治疗 COVID-19 的疗效和安全性:临床试验的系统评价和荟萃分析。
Sci Rep. 2021 May 26;11(1):11022. doi: 10.1038/s41598-021-90551-6.
10
First electrochemical evaluation of favipiravir used as an antiviral option in the treatment of COVID-19: A study of its enhanced voltammetric determination in cationic surfactant media using a boron-doped diamond electrode.首电化学评价法来评估法匹拉韦在治疗 COVID-19 方面的抗病毒作用:使用掺硼金刚石电极在阳离子表面活性剂介质中增强伏安法测定法匹拉韦。
Anal Chim Acta. 2021 May 15;1159:338418. doi: 10.1016/j.aca.2021.338418. Epub 2021 Mar 18.